SEC Form 4Coverage since Jun 3, 2026
$DRTS insider trading
Over the last 12 months, Alpha Tau Medical insiders reported no purchases and 8 sales totaling $1.3M across SEC Form 4 filings. 75% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $1.3M 8 events
- Events · 12m
- 8 Form 4 filings, grouped
- Insiders · 12m
- 1 distinct reporters
- 10b5-1 share
- 75% pre-arranged plans
Side
Price · $DRTS · 12Mvia TradingView
Top insiders · 12m
Levy RaphiChief Financial Officer8× · $1.3M
All insider trades
8 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | Levy RaphiChief Financial Officer · O | ▼ Sale | 2,270 | $14 | $32K | -2.5% | plan |
| Jul 2, 2026 | Levy RaphiChief Financial Officer · O | ▼ Sale | 17,873 | $13 | $232K | -16.5% | plan |
| Jul 1, 2026 | Levy RaphiChief Financial Officer · O | ▼ Sale | 2,127 | $13.02 | $28K | -2.3% | plan |
| Jun 30, 2026 | Levy RaphiChief Financial Officer · O | ▼ Sale | 20,000 | $12 | $240K | -18.2% | plan |
| Jun 25, 2026 | Levy RaphiChief Financial Officer · O | ▼ Sale | 20,000 | $11 | $220K | -15.4% | plan · 2 tranches |
| Jun 23, 2026 | Levy RaphiChief Financial Officer · O | ▼ Sale | 17,500 | $9.55 | $167K | -11.8% | plan · 2 tranches |
| Jun 3, 2026 | Levy RaphiChief Financial Officer · O | ▼ Sale | 15,000 | $10.76 | $161K | -9.2% | — |
| Jun 3, 2026 | Levy RaphiChief Financial Officer · O | ▼ Sale | 17,500 | $10.9 | $191K | -9.7% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $DRTS feed.